var data={"title":"Diagnostic evaluation of a pleural effusion in adults: Initial testing","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Diagnostic evaluation of a pleural effusion in adults: Initial testing</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/contributors\" class=\"contributor contributor_credentials\">John E Heffner, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/contributors\" class=\"contributor contributor_credentials\">V Courtney Broaddus, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/contributors\" class=\"contributor contributor_credentials\">Geraldine Finlay, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 03, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Determining the cause of a pleural effusion is greatly facilitated by analysis of the pleural fluid. Thoracentesis is a simple bedside procedure with imaging guidance that permits fluid to be rapidly sampled, visualized, examined microscopically, and quantified for chemical and cellular content. A systematic approach to analysis of the fluid in conjunction with the clinical presentation allows clinicians to diagnose the cause of an effusion, narrow the differential diagnoses, and design a management plan in a majority of patients who undergo pleural fluid analysis. </p><p>An approach to pleural fluid analysis will be presented here. Pleural fluid microbiologic tests, pleural imaging, the technique of thoracentesis, and an approach to pleural effusions of uncertain etiology after the initial evaluation are discussed separately. (See <a href=\"topic.htm?path=imaging-of-pleural-effusions-in-adults\" class=\"medical medical_review\">&quot;Imaging of pleural effusions in adults&quot;</a> and <a href=\"topic.htm?path=ultrasound-guided-thoracentesis\" class=\"medical medical_review\">&quot;Ultrasound-guided thoracentesis&quot;</a> and <a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology\" class=\"medical medical_review\">&quot;Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology&quot;</a> and <a href=\"topic.htm?path=tuberculous-pleural-effusion\" class=\"medical medical_review\">&quot;Tuberculous pleural effusion&quot;</a> and <a href=\"topic.htm?path=pleural-effusions-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Pleural effusions in HIV-infected patients&quot;</a> and <a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults\" class=\"medical medical_review\">&quot;Parapneumonic effusion and empyema in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">INDICATIONS FOR THORACENTESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The indication for diagnostic thoracentesis is the new finding of a pleural effusion. Observation, in lieu of diagnostic thoracentesis, may be warranted in uncomplicated heart failure and viral pleurisy. In the former setting, the clinical diagnosis is usually secure; in the latter, there is typically a small amount of fluid. However, if the clinical situation is atypical or does not progress as anticipated, thoracentesis should be performed. The indications and contraindications of thoracentesis are presented separately. (See <a href=\"topic.htm?path=ultrasound-guided-thoracentesis\" class=\"medical medical_review\">&quot;Ultrasound-guided thoracentesis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4636315\"><span class=\"h1\">CONDITIONS DIAGNOSED BY THORACENTESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Only a select number of diagnoses can be established definitively by thoracentesis. These include effusions as a result of malignancy, empyema, tuberculous pleurisy, fungal infection of the pleural space, chylothorax, cholesterol effusion, urinothorax, esophageal rupture, hemothorax, peritoneal dialysis, and extravascular migration of a central venous catheter (<a href=\"image.htm?imageKey=PULM%2F50027\" class=\"graphic graphic_table graphicRef50027 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/1\" class=\"abstract_t\">1</a>]. Rarer conditions that can be diagnosed by thoracentesis include glycinothorax, cerebrospinal fluid leakage, and parasitic infection of the pleural space [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/1\" class=\"abstract_t\">1</a>]. </p><p>Positive pleural fluid lupus erythematosus (LE) cell preparation tests, pleural fluid antinuclear&nbsp;antibodies (ANA) titers &ge;1:160, and a pleural fluid to serum ANA ratio &ge;1 had previously been considered diagnostic of lupus pleuritis. However, none of these findings occurs solely in lupus pleuritis. Most clinical laboratories no longer perform lupus cell preparation tests, which are lengthy and complex [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/2-4\" class=\"abstract_t\">2-4</a>]. Although LE cells may be incidentally detected by pleural fluid cytology, this finding has low diagnostic utility. This is because LE cells have been identified in routine pleural fluid cytologic examinations in non-lupus related effusions (eg, malignancy, rheumatoid arthritis) [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/2,5,6\" class=\"abstract_t\">2,5,6</a>]. Similarly, small case series suggest that pleural fluid ANA titer &ge;1:160 is not diagnostic of lupus pleuritis (specificity of 83 percent) [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/7\" class=\"abstract_t\">7</a>] because such titers can also be found in exudative, parapneumonic, and malignancy-associated effusions [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/7-10\" class=\"abstract_t\">7-10</a>]. Even an extremely high pleural fluid ANA &gt;1:640 can occur in malignant effusions [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/10\" class=\"abstract_t\">10</a>]. A pleural fluid ANA titer &ge;1:160, however, remains a sensitive (86 to 100 percent) tool for detecting lupus pleuritis in patients with a known diagnosis of lupus [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/7-11\" class=\"abstract_t\">7-11</a>] thereby differentiating between lupus pleuritis and other causes of pleural effusions in lupus patients. Using the ratio of pleural effusion to serum ANA of &ge;1 [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/7,9,10\" class=\"abstract_t\">7,9,10</a>] or ANA staining pattern in pleural fluid do not provide any additional diagnostic value for lupus pleuritis [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/8,10\" class=\"abstract_t\">8,10</a>]. Thus, measuring pleural fluid ANA titers has better negative predictive value than positive predictive value and appears to be useful only for excluding the diagnosis of lupus pleuritis, particularly in patients who have a known diagnosis of SLE. (See <a href=\"topic.htm?path=pulmonary-manifestations-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">&quot;Pulmonary manifestations of systemic lupus erythematosus in adults&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PLEURAL FLUID ANALYSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tests routinely performed on pleural fluid include cell count and cell differential, pH, protein, lactate dehydrogenase (LDH), and glucose. Additional commonly performed tests in selected patients include amylase, cholesterol, triglycerides, N-terminal pro-brain natriuretic peptide (BNP), creatinine, adenosine deaminase, gram and acid-fast bacillus (AFB) stain, bacterial and AFB culture, and cytology.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Gross appearance</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Initial diagnostic clues can be obtained by gross inspection of pleural fluid as it is being aspirated from the patient's chest [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/1\" class=\"abstract_t\">1</a>]. Observations that are helpful for diagnosis are listed in the table (<a href=\"image.htm?imageKey=PULM%2F74757\" class=\"graphic graphic_table graphicRef74757 \">table 2</a>).</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Characterization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pleural fluid is next characterized as either a transudate or an exudate. (See <a href=\"#H8\" class=\"local\">'Diagnostic criteria'</a> below.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Transudates</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transudates result from imbalances in hydrostatic and oncotic pressures in the chest, as occur with CHF and nephrosis, or conditions external to the pleural space. Examples of the latter include movement of fluid from the peritoneal, cerebrospinal, or retroperitoneal spaces, or from iatrogenic causes, such as crystalloid infusion through a central venous catheter that has migrated into the mediastinum or pleural space. Nevertheless, transudates have a limited number of diagnostic possibilities that can usually be discerned from the patient's clinical presentation (<a href=\"image.htm?imageKey=PULM%2F73530\" class=\"graphic graphic_table graphicRef73530 \">table 3</a>).</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Exudates</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In contrast, exudative effusions present more of a diagnostic challenge. Disease in virtually any organ can cause exudative pleural effusions by a variety of mechanisms, including infection, malignancy, immunologic responses, lymphatic abnormalities, noninfectious inflammation, iatrogenic causes, and movement of fluid from below the diaphragm (<a href=\"image.htm?imageKey=PULM%2F54055\" class=\"graphic graphic_table graphicRef54055 \">table 4</a>).</p><p>Exudates result primarily from pleural and lung inflammation (resulting in increased entry of fluid and protein due to elevated capillary permeability) or from impaired lymphatic drainage of the pleural space (resulting in a decreased removal of pleural fluid and protein). Exudates can also result from movement of fluid from the peritoneal space, as seen with acute or chronic pancreatitis, chylous ascites, and peritoneal carcinomatosis. (See <a href=\"topic.htm?path=mechanisms-of-pleural-liquid-accumulation-in-disease\" class=\"medical medical_review\">&quot;Mechanisms of pleural liquid accumulation in disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Diagnostic criteria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The Light's Criteria Rule is a traditional method of differentiating transudates and exudates that measures serum and pleural fluid protein and LDH [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/12\" class=\"abstract_t\">12</a>]. Abbreviated versions of Light's Criteria Rule have similar diagnostic accuracy and have been recommended for clinical use [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/13,14\" class=\"abstract_t\">13,14</a>].</p><p>According to the traditional Light's Criteria Rule, if at least one of the following three criteria (ie, component tests of the rule) is fulfilled, the fluid is defined as an exudate [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/12\" class=\"abstract_t\">12</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural fluid <span class=\"nowrap\">protein/serum</span> protein ratio greater than 0.5, or</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural fluid <span class=\"nowrap\">LDH/serum</span> LDH ratio greater than 0.6, or</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural fluid LDH greater than two-thirds the upper limits of the laboratory's normal serum LDH</p><p/><p>Combining results of two or more dichotomous tests into a diagnostic rule, as done by the Light&rsquo;s Criteria Rule, wherein only one component test result needs to be positive to make the rule result positive always increases sensitivity at the expense of decreasing specificity of the rule. As would be expected, therefore, the sensitivity of the Light&rsquo;s Criteria Rule is higher than the sensitivity of each of the three component tests of the rule but the specificity of the rule is lower than its individual components. This tradeoff of higher sensitivity for lower specificity in the design of Light&rsquo;s Criteria Rule is appropriate for evaluating pleural fluid because it is important that exudates not be missed, since they can have important prognostic implications. Some transudates, however, may be misclassified as an exudate because of the decreased specificity of the rule [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/15\" class=\"abstract_t\">15</a>].</p><p>Light's criteria have been criticized for including both the pleural fluid <span class=\"nowrap\">LDH/serum</span> LDH ratio and the pleural fluid LDH [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/13\" class=\"abstract_t\">13</a>] because they are highly correlated [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/13,16\" class=\"abstract_t\">13,16</a>].</p><p>Alternative diagnostic criteria also exist. A meta-analysis of eight studies (1448 patients) examined pleural fluid tests and found that several tests identified exudates with accuracy similar to those used in Light's criteria, but did not require concurrent measurement of serum protein or LDH [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/13\" class=\"abstract_t\">13</a>]. Proposed two-criteria and three-criteria diagnostic rules, which require one criterion to be met to define an exudate, include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Two-test rule</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pleural fluid cholesterol greater than 45 <span class=\"nowrap\">mg/dL</span></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pleural fluid LDH greater than 0.45 times the upper limit of the laboratory's normal serum LDH</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Three-test rule</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pleural fluid protein greater than 2.9 <span class=\"nowrap\">g/dL</span> (29 <span class=\"nowrap\">g/L)</span></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pleural fluid cholesterol greater than 45 <span class=\"nowrap\">mg/dL</span> (1.165 <span class=\"nowrap\">mmol/L)</span></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pleural fluid LDH greater than 0.45 times the upper limit of the laboratory's normal serum LDH</p><p/><p>The previous pleural fluid LDH cutoff point for differentiating between exudates and transudates in the traditional Light's criteria rule was 67 percent of (or 0.67 times) the upper limit of normal serum LDH. This has been changed to 45 percent, based on reanalysis of each criterion individually [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/13,16\" class=\"abstract_t\">13,16</a>]. All available tests may misclassify pleural fluid as exudates or transudates when values are near the cutoff points [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/12,13,16\" class=\"abstract_t\">12,13,16</a>]. Thus, clinical judgment is required when evaluating patients with borderline test results [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/17\" class=\"abstract_t\">17</a>].</p><p>The need for clinical judgment is further underscored by recent observations that different LDH and protein laboratory assays perform differently when performed for pleural as opposed to serum samples [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/18\" class=\"abstract_t\">18</a>]. Consequently, classification of pleural fluid into transudate or exudate using Light&rsquo;s criteria with different analytical platforms and assay methodologies may have up to 18 percent discordancy [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/18\" class=\"abstract_t\">18</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Chemical and biochemical analysis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The measurement of various chemical and biochemical constituents of pleural fluid can provide useful information. Pleural fluid protein, LDH, and glucose are routinely assayed while other chemical and biochemical tests are ordered in specific clinical situations. </p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Protein</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most transudates have absolute total protein concentrations below 3.0 <span class=\"nowrap\">g/dL</span> (30 <span class=\"nowrap\">g/L),</span> although acute diuresis in heart failure can elevate protein levels into the exudative range [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/19-21\" class=\"abstract_t\">19-21</a>]. However, such patients have a serum to pleural fluid albumin gradient (the difference between the serum and pleural values) greater than 1.2 <span class=\"nowrap\">g/dL</span> (12 <span class=\"nowrap\">g/L),</span> or a protein gradient &gt;3.1 <span class=\"nowrap\">g/dL,</span> which correctly categorizes their effusions as transudates [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/21,22\" class=\"abstract_t\">21,22</a>]. Elevated blood N-terminal pro-brain natriuretic peptide (NT-proBNP) also supports the diagnosis of heart failure when Light&rsquo;s criteria yield results in the exudative range [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/23\" class=\"abstract_t\">23</a>]. (See <a href=\"#H17\" class=\"local\">'N-terminal pro-BNP'</a> below.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tuberculous pleural effusions virtually always have total protein concentrations above 4.0 <span class=\"nowrap\">g/dL</span> (40 <span class=\"nowrap\">g/L)</span> [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/12\" class=\"abstract_t\">12</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>When pleural fluid protein concentrations are in the 7.0 to 8.0 <span class=\"nowrap\">g/dL</span> (70 to 80 <span class=\"nowrap\">g/L)</span> range, Waldenstr&ouml;m&rsquo;s macroglobulinemia and multiple myeloma should be considered [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/24,25\" class=\"abstract_t\">24,25</a>]</p><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">LDH</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The level of pleural fluid LDH is one of the key criteria for differentiating transudates and exudates (see <a href=\"#H8\" class=\"local\">'Diagnostic criteria'</a> above). Several specific disease associations have been noted with pleural fluid protein and LDH levels:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural fluid LDH levels above 1000 <span class=\"nowrap\">IU/L</span> (with upper limit of normal for serum of 200 <span class=\"nowrap\">IU/L)</span> are characteristically found in empyema [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/26\" class=\"abstract_t\">26</a>], rheumatoid pleurisy [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/27\" class=\"abstract_t\">27</a>], and pleural paragonimiasis [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/28\" class=\"abstract_t\">28</a>], and are sometimes observed with malignancy.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural fluid secondary to Pneumocystis jirovecii pneumonia has the characteristic finding of a pleural <span class=\"nowrap\">fluid/serum</span> LDH ratio greater than 1.0 and a pleural <span class=\"nowrap\">fluid/serum</span> protein ratio of less than 0.5 [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/29\" class=\"abstract_t\">29</a>]. Such a pattern may also be suggestive of malignancy. Urinothorax is another cause of elevated pleural fluid LDH associated with low pleural fluid protein levels [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/30\" class=\"abstract_t\">30</a>].</p><p/><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Cholesterol</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleural cholesterol is thought to be derived from degenerating cells and vascular leakage from increased permeability. Measurement of pleural cholesterol has been used to improve the accuracy of differentiating transudative and exudative effusion. A pleural cholesterol level of greater than 45 <span class=\"nowrap\">mg/dL</span> is not by itself a definitive criterion for an exudate, but does figure in the two and three-test rules as noted above [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/13\" class=\"abstract_t\">13</a>]. </p><p>An elevated cholesterol &gt;250 <span class=\"nowrap\">mg/dL</span> defines a cholesterol effusion (also known as pseudochylothorax or chyliform effusion), which can develop in patients with long-standing effusions. (See <a href=\"topic.htm?path=clinical-presentation-diagnosis-and-management-of-cholesterol-effusions#H20969448\" class=\"medical medical_review\">&quot;Clinical presentation, diagnosis and management of cholesterol effusions&quot;, section on 'Diagnosis and differential diagnosis'</a>.) </p><p class=\"headingAnchor\" id=\"H25763845\"><span class=\"h3\">Triglycerides</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Elevated pleural fluid triglyceride concentrations greater than 110 <span class=\"nowrap\">mg/dL</span> supports the diagnosis of a chylothorax, a level less than 50 <span class=\"nowrap\">mg/dL</span> excludes a chylothorax with reasonable likelihood, and an intermediate level between 50 and 110 <span class=\"nowrap\">mg/dL</span> should be followed by lipoprotein analysis of the pleural fluid [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"topic.htm?path=etiology-clinical-presentation-and-diagnosis-of-chylothorax#H9\" class=\"medical medical_review\">&quot;Etiology, clinical presentation, and diagnosis of chylothorax&quot;, section on 'Pleural fluid analysis'</a>.) </p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Glucose</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A low pleural fluid glucose concentration (less than 60 <span class=\"nowrap\">mg/dL</span> [3.33 <span class=\"nowrap\">mmol/liter],</span> or a pleural <span class=\"nowrap\">fluid/serum</span> glucose ratio less than 0.5) narrows the differential diagnosis of the exudate to the following possibilities [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/32\" class=\"abstract_t\">32</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rheumatoid pleurisy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Complicated parapneumonic effusion or empyema</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignant effusion</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tuberculous pleurisy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lupus pleuritis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Esophageal rupture</p><p/><p>All other exudates have pleural fluid glucose concentration similar to that of blood glucose. All transudates have pleural fluid glucose concentrations similar to blood glucose except for pleural effusions with elevated pleural fluid glucose concentrations secondary to misplaced central venous catheters that infuse glucose-containing fluids into the pleural space [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/33\" class=\"abstract_t\">33</a>] or migration of peritoneal dialysate fluid from the intraperitoneal space into the pleural space [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/34\" class=\"abstract_t\">34</a>].</p><p>The mechanism responsible for a low pleural fluid glucose depends upon the underlying disease. Specific examples include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased diffusion of glucose from blood to pleural fluid with rheumatoid pleurisy [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/35,36\" class=\"abstract_t\">35,36</a>] or malignancy [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/37\" class=\"abstract_t\">37</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased utilization of glucose by constituents of pleural fluid, such as neutrophils, bacteria (empyema), and malignant cells [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/38\" class=\"abstract_t\">38</a>]</p><p/><p>The lowest glucose concentrations are found in rheumatoid pleurisy and empyema, with glucose being undetectable in some cases. In comparison, when the glucose concentration is low in tuberculous pleurisy, lupus pleuritis, and malignancy, it usually falls into the range of 30 to 50 <span class=\"nowrap\">mg/dL</span> (1.66 to 2.78 <span class=\"nowrap\">mmol/liter)</span> [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/32\" class=\"abstract_t\">32</a>].</p><p class=\"headingAnchor\" id=\"H2582864087\"><span class=\"h3\">Creatinine</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleural fluid creatinine represents a confirmatory test for urinothorax when a transudate has a pleural <span class=\"nowrap\">fluid/serum</span> creatinine ratio &gt;1 [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/39,40\" class=\"abstract_t\">39,40</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">pH</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleural fluid pH should always be measured in a blood gas machine rather than with a pH meter or pH indicator paper, because the latter will result in inaccurate measurements [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/41,42\" class=\"abstract_t\">41,42</a>]. A pleural fluid pH below 7.30 with a normal arterial blood pH is found with the same diagnoses associated with low pleural fluid glucose concentrations [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/43\" class=\"abstract_t\">43</a>]. The pH of normal pleural fluid is approximately 7.60, due to a bicarbonate gradient between pleural fluid and blood [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/44\" class=\"abstract_t\">44</a>]. Thus, a pH below 7.30 is abnormal. Transudates generally have a pleural fluid pH in the 7.40 to 7.55 range, while the majority of exudates range from 7.30 to 7.45 [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/43\" class=\"abstract_t\">43</a>]. A urinothorax, however, is the only transudate that can have a urine pH &lt;7.40 [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/39\" class=\"abstract_t\">39</a>].</p><p>The mechanisms responsible for pleural fluid acidosis (pH &lt;7.30) include;</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased acid production by pleural fluid cells and bacteria (empyema) [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/38,45\" class=\"abstract_t\">38,45</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased hydrogen ion efflux from the pleural space, due to pleuritis, tumor, or pleural fibrosis. Specific examples include malignancy [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/37\" class=\"abstract_t\">37</a>], rheumatoid pleurisy [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/35,36\" class=\"abstract_t\">35,36</a>], and tuberculous pleurisy.</p><p/><p>A low pleural fluid pH has diagnostic, prognostic, and therapeutic implications for patients with parapneumonic and malignant effusions [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/46\" class=\"abstract_t\">46</a>]. Patients with a low pleural fluid pH malignant effusion have a high initial positive yield on pleural fluid cytology. They also tend to have a shorter survival and poorer response to chemical pleurodesis than those with a pH &gt;7.30, although the strength of these associations do not provide prognostic value for individual patients [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/47-49\" class=\"abstract_t\">47-49</a>]. Clinicians should not use a low pleural fluid pH as the sole criterion for the decision to forego pleurodesis. (See <a href=\"topic.htm?path=management-of-malignant-pleural-effusions\" class=\"medical medical_review\">&quot;Management of malignant pleural effusions&quot;</a>.)</p><p>A parapneumonic effusion with a low pleural fluid pH (&le;7.15) indicates a high likelihood of necessity for pleural space drainage [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/50-52\" class=\"abstract_t\">50-52</a>]. (See <a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults\" class=\"medical medical_review\">&quot;Parapneumonic effusion and empyema in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Amylase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although not routinely tested in pleural fluid samples, amylase measurements can assist when pancreatic or esophageal etiologies of an effusion appear possible. The finding of an amylase-rich pleural effusion, defined as either a pleural fluid amylase greater than the upper limits of normal for serum amylase or a pleural fluid to serum amylase ratio greater than 1, narrows the differential diagnosis of an exudative effusion to the following major possibilities:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute pancreatitis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic pancreatic pleural effusion</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Esophageal rupture</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignancy</p><p/><p>Pleural fluid amylase, however, has low discriminative value for differentiating benign from malignant effusions so it is not routinely performed for this reason.</p><p>Other rare causes of an amylase-rich pleural effusion include pneumonia, ruptured ectopic pregnancy, hydronephrosis, and cirrhosis [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/53\" class=\"abstract_t\">53</a>]. Pancreatic disease is associated with pancreatic isoenzymes, while malignancy and esophageal rupture are characterized by a predominance of salivary isoenzymes [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/53\" class=\"abstract_t\">53</a>]. One case report observed an increase in pleural fluid salivary amylase isoenzymes in a patient with a pleural effusion due to multiple myeloma [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/54\" class=\"abstract_t\">54</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Adenosine deaminase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Measurement of adenosine deaminase (ADA) may be helpful to distinguish between malignant and tuberculous pleurisy when an exudative effusion is lymphocytic, but initial cytology and smear and culture for tuberculosis are negative [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/55-58\" class=\"abstract_t\">55-58</a>]. The level of ADA is typically greater than 35 to 50 <span class=\"nowrap\">U/L</span> in tuberculous pleural effusions [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/56,59\" class=\"abstract_t\">56,59</a>] and less than 40 <span class=\"nowrap\">U/L</span> in 94 percent of malignant pleural effusions [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/60\" class=\"abstract_t\">60</a>]. The most common diagnostic threshold used to establish tuberculous pleural effusions is a value greater than 40 <span class=\"nowrap\">U/L</span> [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/58\" class=\"abstract_t\">58</a>]. False negative and false positive ADA results do occur, so ADA results need to be considered in the context of other features of the patient&rsquo;s clinical presentation [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/59\" class=\"abstract_t\">59</a>]. ADA testing may be more valuable for ruling in the diagnosis of tuberculous pleurisy in geographic locations with high prevalence of tuberculosis, although the negative predictive value of ADA testing remains high in lower tuberculosis prevalence regions [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/61-63\" class=\"abstract_t\">61-63</a>]. Coexisting conditions, however, that cause exudative pleural effusions, such as uremic pleuritis, decrease the diagnostic utility of ADA even in high tuberculosis prevalence regions [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/64\" class=\"abstract_t\">64</a>]. For patients with neutrophil-predominant pleural effusions and elevated pleural fluid ADA levels, the presence of coexisting nodular lung lesions supports a diagnosis of tuberculous pleurisy while the presence of intrapleural loculations supports a diagnosis of parapneumonic effusion [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/65\" class=\"abstract_t\">65</a>]. </p><p>Some studies suggest greater diagnostic value of pleural fluid interferon gamma (T.SPOT.TB <span class=\"nowrap\">and/or</span> QuantiFERON assays) in differentiating malignant from tuberculous lymphocytic exudates, but the lower cost and ready availability of ADA testing has promoted its use in this setting [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/66,67\" class=\"abstract_t\">66,67</a>]. For pleural fluid interferon gamma testing, primary studies [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/68-72\" class=\"abstract_t\">68-72</a>] report varying diagnostic utility and a meta-analysis identifies problems with the quality of primary studies and inadequate diagnostic performance of pleural fluid interferon gamma testing to allow it to serve as a standalone test [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/73\" class=\"abstract_t\">73</a>]. (See <a href=\"topic.htm?path=tuberculous-pleural-effusion\" class=\"medical medical_review\">&quot;Tuberculous pleural effusion&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">N-terminal pro-BNP</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multiple studies have demonstrated that natriuretic peptides in the blood and pleural fluid, such as N-terminal pro-brain natriuretic peptide (NT-proBNP), brain natriuretic peptide (BNP), and midregion pro-atrial natriuretic peptide (MR-proANP) are diagnostic markers for heart failure [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/74-83\" class=\"abstract_t\">74-83</a>]. Measuring pleural fluid NT-proBNP, however, has questionable added value as compared with blood NT-proBNP levels, which are elevated in heart failure and have a high degree of correlation with pleural NT-proBNP results [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/23\" class=\"abstract_t\">23</a>]. Moreover, a meta-analysis suggests that additional high quality primary studies are needed to evaluate the diagnostic accuracy of pleural fluid natriuretic peptides [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/82\" class=\"abstract_t\">82</a>], and conditions other than heart failure can increase pleural fluid levels in critically ill patients [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/83\" class=\"abstract_t\">83</a>]. Blood NT-proBNP testing is useful for diagnosing a cardiogenic pleural effusion in patients whose pleural fluid appears exudative (eg, due to diuresis). (See <a href=\"topic.htm?path=natriuretic-peptide-measurement-in-heart-failure\" class=\"medical medical_review\">&quot;Natriuretic peptide measurement in heart failure&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2578926\"><span class=\"h3\">Procalcitonin</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Interest in serum procalcitonin as a diagnostic and prognostic marker for patients with bacterial tissue infections and sepsis [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/84\" class=\"abstract_t\">84</a>] has directed attention to a possible value for pleural fluid procalcitonin in differentiating parapneumonic or tuberculous pleural effusions from other causes of exudative effusions and also for differentiating parapneumonic from tuberculous pleural effusions. However, studies have not demonstrated sufficient diagnostic utility of pleural fluid procalcitonin in these settings to recommend its use [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/85-87\" class=\"abstract_t\">85-87</a>].</p><p class=\"headingAnchor\" id=\"H3293930968\"><span class=\"h2\">Cytology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cytological analysis of pleural fluid can establish the diagnosis of malignant pleural effusions, but the test has an overall sensitivity of approximately 60 percent [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/88\" class=\"abstract_t\">88</a>], which may increase by 15 percent with a second thoracentesis pleural fluid sample [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/89\" class=\"abstract_t\">89</a>]. The sensitivity of pleural fluid cytology varies depending on the histological type of the underlying malignancy; among patients with lung cancer, for instance, cytology has a sensitivity of 78 percent for adenocarcinoma, 53 percent for small cell carcinoma, and 25 percent for squamous cell carcinomas [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/88\" class=\"abstract_t\">88</a>]. The diagnostic yield of pleural fluid cytology does not appear to depend on the volume of fluid sent for cytological smear and cell block analysis [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/90\" class=\"abstract_t\">90</a>]. Further details are provided separately. (See <a href=\"topic.htm?path=selection-of-modality-for-diagnosis-and-staging-of-patients-with-suspected-non-small-cell-lung-cancer#H3750441510\" class=\"medical medical_review\">&quot;Selection of modality for diagnosis and staging of patients with suspected non-small cell lung cancer&quot;, section on 'Pleural (T2, T3, M1a)'</a> and <a href=\"topic.htm?path=procedures-for-tissue-biopsy-in-patients-with-suspected-non-small-cell-lung-cancer#H13383698\" class=\"medical medical_review\">&quot;Procedures for tissue biopsy in patients with suspected non-small cell lung cancer&quot;, section on 'Thoracentesis'</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Cancer-related biomarkers</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multiple biomarkers are expressed by cancer cells or their environment. Modern immunohistochemistry techniques can detect these biomarkers in pleural fluid and provide opportunities to diagnose pleural malignancies when the results of standard cytology are noncontributory. Although promising, clinical applicability of cancer-related biomarkers to establish a diagnosis of pleural malignancy is limited by the lack of standardized laboratory analysis methodologies and a shortage of studies that validate positive studies.</p><p>No single pleural fluid biomarker is accurate enough for routine use in the diagnostic evaluation of pleural effusion [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/91\" class=\"abstract_t\">91</a>]. Measuring a panel of tumor markers (eg, carcinoembryonic antigen [CEA], carbohydrate antigen [CA] 125, CA 15-3, CA 19-9, cytokeratin fragment CYFRA 21-1) in pleural fluid has also been examined [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/92,93\" class=\"abstract_t\">92,93</a>]. At levels that provide 100 percent specificity, individual sensitivities are less than 30 percent and a combination of four markers (CEA, CA 125, CA 15-3, and CYFRA 21) only reached 54 percent sensitivity in one study [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/93\" class=\"abstract_t\">93</a>]. Similar results were reported in two meta-analyses that looked at various combinations of pleural fluid tumor markers [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/92,94\" class=\"abstract_t\">92,94</a>]. A meta-analysis observed that the combination of CEA, CYFRA 21-1, and CA19-9 had a sensitivity for adenocarcinoma-associated malignant effusions of 95.06 percent, with an area under the receiver operating curve (AUC) of 0.95 [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/95\" class=\"abstract_t\">95</a>]. </p><p>Mesothelin is a glycoprotein that is highly over expressed in malignant mesothelioma cells [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/96\" class=\"abstract_t\">96</a>]. Mesothelin levels measured in serum and pleural fluid may provide adjuvant diagnostic values with high specificity but low sensitivity for patients with suspected mesothelioma [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/97\" class=\"abstract_t\">97</a>]. The role of soluble mesothelin-related peptides (SMRPs) in the diagnosis of pleural mesothelioma is discussed separately. (See <a href=\"topic.htm?path=presentation-initial-evaluation-and-prognosis-of-malignant-pleural-mesothelioma#H2423291832\" class=\"medical medical_review\">&quot;Presentation, initial evaluation, and prognosis of malignant pleural mesothelioma&quot;, section on 'Biomarkers under investigation'</a>.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Nucleated cells</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The total pleural fluid nucleated cell count is virtually never diagnostic. There are, however, some settings in which the count may be helpful:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Counts above <span class=\"nowrap\">50,000/microL</span> are usually found only in complicated parapneumonic effusions, including empyema</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exudative effusions from bacterial pneumonia, acute pancreatitis, and lupus pleuritis usually have total nucleated cell counts above <span class=\"nowrap\">10,000/microL</span> [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/98\" class=\"abstract_t\">98</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic exudates, typified by tuberculous pleurisy and malignancy, typically have nucleated cell counts below <span class=\"nowrap\">5000/microL</span> [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/98\" class=\"abstract_t\">98</a>]</p><p/><p>The timing of thoracentesis in relation to the acute pleural injury determines the predominant cell type. The early cellular response to pleural injury is neutrophilic. As the time from the acute insult lengthens, if the pleural injury in not ongoing, the effusion develops a mononuclear predominance.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h3\">Lymphocytosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleural fluid lymphocytosis, particularly with lymphocyte counts representing 85 to 95 percent of the total nucleated cells, suggests tuberculous pleurisy, lymphoma, sarcoidosis, chronic rheumatoid pleurisy, yellow nail syndrome, or chylothorax [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/1,99\" class=\"abstract_t\">1,99</a>]. Malignant pleural effusions will be lymphocyte-predominant in over one-half of cases; however, the percentage of lymphocytes is usually between 50 and 70 percent [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/99\" class=\"abstract_t\">99</a>]. Some drug-induced pleural effusions, such as those caused by <a href=\"topic.htm?path=dasatinib-drug-information\" class=\"drug drug_general\">dasatinib</a> [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/100\" class=\"abstract_t\">100</a>], are lymphocyte predominant. (See <a href=\"topic.htm?path=tuberculous-pleural-effusion\" class=\"medical medical_review\">&quot;Tuberculous pleural effusion&quot;</a> and <a href=\"topic.htm?path=aids-related-lymphomas-primary-effusion-lymphoma\" class=\"medical medical_review\">&quot;AIDS-related lymphomas: Primary effusion lymphoma&quot;</a> and <a href=\"topic.htm?path=etiology-clinical-presentation-and-diagnosis-of-chylothorax\" class=\"medical medical_review\">&quot;Etiology, clinical presentation, and diagnosis of chylothorax&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h3\">Eosinophilia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleural fluid eosinophilia (defined by pleural fluid eosinophils representing more than 10 percent of the total nucleated cells) occurs with both malignant and benign etiologies of pleural effusions [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/101\" class=\"abstract_t\">101</a>]. The differential diagnosis of pleural fluid eosinophilia includes [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/101-104\" class=\"abstract_t\">101-104</a>]: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pneumothorax</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemothorax</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary infarction</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Benign asbestos pleural effusion</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Parasitic disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fungal infection (coccidioidomycosis, cryptococcosis, histoplasmosis)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drugs</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Catamenial pneumothorax with pleural effusion</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignancy (carcinoma, lymphoma, myeloma)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tuberculous pleurisy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Parapneumonic effusions</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic eosinophilic pneumonia</p><p/><p>Two studies have noted that the presence or absence of eosinophilia provides no diagnostic value for ruling in or out a malignant pleural effusion [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/105,106\" class=\"abstract_t\">105,106</a>]. Another case series of 6801 pleural fluid analyses from 3942 patients noted no discriminative properties of pleural fluid eosinophilia defined as &gt;10 percent eosinophils for malignancy but some diagnostic value with a higher cut off point of &gt;15 percent pleural fluid eosinophils (sensitivity and specificity 66 percent and 68 percent respectively). (See <a href=\"topic.htm?path=pleural-fluid-eosinophilia\" class=\"medical medical_review\">&quot;Pleural fluid eosinophilia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h3\">Mesothelial cells</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mesothelial cells are found in small numbers in normal pleural fluid, are prominent in transudative pleural effusions, and are variable in exudative effusions. The major clinical significance of mesothelial cells in exudates is that tuberculosis is unlikely if there are more than 5 percent mesothelial cells [<a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/99,107,108\" class=\"abstract_t\">99,107,108</a>].</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A listing of most of the causes of pleural effusion, differentiated by whether the fluid is transudative or exudative, is given in the tables (<a href=\"image.htm?imageKey=PULM%2F50027\" class=\"graphic graphic_table graphicRef50027 \">table 1</a> and <a href=\"image.htm?imageKey=PULM%2F74757\" class=\"graphic graphic_table graphicRef74757 \">table 2</a>). The evaluation of pleural effusions of undetermined etiology after the above evaluation is discussed separately. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology\" class=\"medical medical_review\">&quot;Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1018584325\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-pleural-effusion\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Pleural effusion&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=pleural-effusion-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Pleural effusion (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=thoracentesis-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Thoracentesis (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H365048\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Analysis of pleural fluid can help to establish a diagnosis or at least limit the differential diagnoses in the majority of patients who undergo the thoracentesis (<a href=\"image.htm?imageKey=PULM%2F50027\" class=\"graphic graphic_table graphicRef50027 \">table 1</a>). (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Characteristics of the gross appearance of pleural fluid that are helpful in identifying the cause of the effusion are listed in the table (<a href=\"image.htm?imageKey=PULM%2F74757\" class=\"graphic graphic_table graphicRef74757 \">table 2</a>). (See <a href=\"#H4\" class=\"local\">'Gross appearance'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An important initial step in the analysis of pleural fluid is to ascertain whether the fluid is a transudate or an exudate. Transudates are largely due to imbalances in hydrostatic and oncotic pressures in the chest (<a href=\"image.htm?imageKey=PULM%2F73530\" class=\"graphic graphic_table graphicRef73530 \">table 3</a>). Exudates are caused by a variety of mechanisms, including infection, malignancy, immunologic responses, lymphatic abnormalities, noninfectious inflammation, and trauma (<a href=\"image.htm?imageKey=PULM%2F54055\" class=\"graphic graphic_table graphicRef54055 \">table 4</a>). (See <a href=\"#H5\" class=\"local\">'Characterization'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>According to Light's traditional criteria, if at least one of the following three criteria is present, the fluid is defined as an exudate (see <a href=\"#H8\" class=\"local\">'Diagnostic criteria'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pleural fluid <span class=\"nowrap\">protein/serum</span> protein ratio greater than 0.5</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pleural fluid lactate dehydrogenase <span class=\"nowrap\">(LDH)/serum</span> LDH ratio greater than 0.6</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pleural fluid LDH greater than two-thirds the upper limits of the laboratory's normal serum LDH</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other sets of criteria, called the two and three test rules have been developed to avoid needing simultaneous measurement of LDH or protein in the serum. (See <a href=\"#H8\" class=\"local\">'Diagnostic criteria'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A low pleural fluid glucose concentration (less than 60 <span class=\"nowrap\">mg/dL</span> [3.33 <span class=\"nowrap\">mmol/liter])</span> or a pleural <span class=\"nowrap\">fluid/serum</span> glucose ratio less than 0.5 narrows the major differential diagnoses to rheumatoid pleurisy, tuberculous pleurisy or other infection, lupus pleuritis, malignant effusion, and esophageal rupture. A pleural <span class=\"nowrap\">fluid/serum</span> glucose ratio greater than 1 suggests the presence of the infusion of glucose-containing intravenous fluids or intraperitoneal dialysate into the pleural space. (See <a href=\"#H13\" class=\"local\">'Glucose'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The measurement of cholesterol, triglycerides, amylase, creatinine, and pH can provide useful additional information in selected patients. (See <a href=\"#H12\" class=\"local\">'Cholesterol'</a> above and <a href=\"#H25763845\" class=\"local\">'Triglycerides'</a> above and <a href=\"#H14\" class=\"local\">'pH'</a> above and <a href=\"#H15\" class=\"local\">'Amylase'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Measurement of adenosine deaminase may be helpful when an effusion is lymphocytic and the initial smear and culture for tuberculosis are negative. The level of adenosine deaminase (ADA) is typically greater than 40 <span class=\"nowrap\">U/L</span> in tuberculous pleural effusions but can be elevated to this level in other clinical conditions. (See <a href=\"#H16\" class=\"local\">'Adenosine deaminase'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Predominant populations of neutrophils, lymphocytes, or eosinophils in the pleural fluid can help narrow the diagnostic possibilities. (See <a href=\"#H19\" class=\"local\">'Nucleated cells'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural fluid cytological examination has a sensitivity of 60 percent for pleural malignancy. The sensitivity varies depending on the histopathology of the underlying malignancy. (See <a href=\"#H3293930968\" class=\"local\">'Cytology'</a> above and <a href=\"topic.htm?path=procedures-for-tissue-biopsy-in-patients-with-suspected-non-small-cell-lung-cancer#H13383698\" class=\"medical medical_review\">&quot;Procedures for tissue biopsy in patients with suspected non-small cell lung cancer&quot;, section on 'Thoracentesis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The evaluation of pleural effusions of undetermined etiology after the above evaluation is discussed separately. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology\" class=\"medical medical_review\">&quot;Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology&quot;</a>.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/1\" class=\"nounderline abstract_t\">Sahn SA, Huggins JT, San Jose E, et al. The art of pleural fluid analysis. Clin Pulm Med 2013; 20:77.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/2\" class=\"nounderline abstract_t\">Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 2008; 75:361.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/3\" class=\"nounderline abstract_t\">Ferreiro L, Alvarez-Doba&ntilde;o JM, Vald&eacute;s L. Systemic diseases and the pleura. Arch Bronconeumol 2011; 47:361.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/4\" class=\"nounderline abstract_t\">Murin S, Wiedemann HP, Matthay RA. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 1998; 19:641.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/5\" class=\"nounderline abstract_t\">Hunder GG, Pierre RV. In vivo LE cell formation in synovial fluid. Arthritis Rheum 1970; 13:448.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/6\" class=\"nounderline abstract_t\">Funauchi M, Ikoma S, Yu H, et al. A case of progressive systemic sclerosis complicated by massive pleural effusion with elevated CA125. Lupus 2000; 9:382.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/7\" class=\"nounderline abstract_t\">Toworakul C, Kasitanon N, Sukitawut W, et al. Usefulness of pleural effusion antinuclear antibodies in the diagnosis of lupus pleuritis. Lupus 2011; 20:1042.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/8\" class=\"nounderline abstract_t\">Porcel JM, Ordi-Ros J, Esquerda A, et al. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis. Lupus 2007; 16:25.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/9\" class=\"nounderline abstract_t\">Khare V, Baethge B, Lang S, et al. Antinuclear antibodies in pleural fluid. Chest 1994; 106:866.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/10\" class=\"nounderline abstract_t\">Wang DY, Yang PC, Yu WL, et al. Serial antinuclear antibodies titre in pleural and pericardial fluid. Eur Respir J 2000; 15:1106.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/11\" class=\"nounderline abstract_t\">Choi BY, Yoon MJ, Shin K, et al. Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis. Lupus 2015; 24:321.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/12\" class=\"nounderline abstract_t\">Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77:507.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/13\" class=\"nounderline abstract_t\">Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest 1997; 111:970.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/14\" class=\"nounderline abstract_t\">Gonlugur U, Gonlugur TE. The distinction between transudates and exudates. J Biomed Sci 2005; 12:985.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/15\" class=\"nounderline abstract_t\">Kummerfeldt CE, Chiuzan CC, Huggins JT, et al. Improving the predictive accuracy of identifying exudative effusions. Chest 2014; 145:586.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/16\" class=\"nounderline abstract_t\">Porcel JM, Pe&ntilde;a JM, Vicente de Vera C, et al. Bayesian analysis using continuous likelihood ratios for identifying pleural exudates. Respir Med 2006; 100:1960.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/17\" class=\"nounderline abstract_t\">Heffner JE, Highland K, Brown LK. A meta-analysis derivation of continuous likelihood ratios for diagnosing pleural fluid exudates. Am J Respir Crit Care Med 2003; 167:1591.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/18\" class=\"nounderline abstract_t\">Cornes MP, Chadburn AJ, Thomas C, et al. The impact of between analytical platform variability on the classification of pleural effusions into exudate or transudate using Light's criteria. J Clin Pathol 2017; 70:607.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/19\" class=\"nounderline abstract_t\">Chakko SC, Caldwell SH, Sforza PP. Treatment of congestive heart failure. Its effect on pleural fluid chemistry. Chest 1989; 95:798.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/20\" class=\"nounderline abstract_t\">Shinto RA, Light RW. Effects of diuresis on the characteristics of pleural fluid in patients with congestive heart failure. Am J Med 1990; 88:230.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/21\" class=\"nounderline abstract_t\">Romero-Candeira S, Fern&aacute;ndez C, Mart&iacute;n C, et al. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001; 110:681.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/22\" class=\"nounderline abstract_t\">Roth BJ, O'Meara TF, Cragun WH. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 1990; 98:546.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/23\" class=\"nounderline abstract_t\">Porcel JM. Utilization of B-type natriuretic peptide and NT-proBNP in the diagnosis of pleural effusions due to heart failure. Curr Opin Pulm Med 2011; 17:215.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/24\" class=\"nounderline abstract_t\">Winterbauer RH, Riggins RC, Griesman FA, Bauermeister DE. Pleuropulmonary manifestations of Waldenstrom's macroglobulinemia. Chest 1974; 66:368.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/25\" class=\"nounderline abstract_t\">Rodr&iacute;guez JN, Pereira A, Mart&iacute;nez JC, et al. Pleural effusion in multiple myeloma. Chest 1994; 105:622.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/26\" class=\"nounderline abstract_t\">Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980; 69:507.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/27\" class=\"nounderline abstract_t\">Pettersson T, Klockars M, Hellstr&ouml;m PE. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases. Thorax 1982; 37:354.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/28\" class=\"nounderline abstract_t\">Johnson JR, Falk A, Iber C, Davies S. Paragonimiasis in the United States. A report of nine cases in Hmong immigrants. Chest 1982; 82:168.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/29\" class=\"nounderline abstract_t\">Horowitz ML, Schiff M, Samuels J, et al. Pneumocystis carinii pleural effusion. Pathogenesis and pleural fluid analysis. Am Rev Respir Dis 1993; 148:232.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/30\" class=\"nounderline abstract_t\">Garcia-Pachon E, Padilla-Navas I. Urinothorax: case report and review of the literature with emphasis on biochemical diagnosis. Respiration 2004; 71:533.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/31\" class=\"nounderline abstract_t\">Staats BA, Ellefson RD, Budahn LL, et al. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 1980; 55:700.</a></li><li class=\"breakAll\">Sahn SA. Pathogenesis and clinical features of diseases associated with a low pleural fluid glucose. In: The Pleura in Health and Disease, Chretien J, Bignon J, Hirsch A (Eds), Marcel Dekker, New York 1985. p.267-285.</li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/33\" class=\"nounderline abstract_t\">Duntley P, Siever J, Korwes ML, et al. Vascular erosion by central venous catheters. Clinical features and outcome. Chest 1992; 101:1633.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/34\" class=\"nounderline abstract_t\">Maude RR, Barretti M. Severe &quot;sweet&quot; pleural effusion in a continuous ambulatory peritoneal dialysis patient. Respir Med Case Rep 2014; 13:1.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/35\" class=\"nounderline abstract_t\">Carr DT, McGuckin WF. Pleural fluid glucose. Serial observation of its concentration following oral administration of glucose to patients with rheumatoid pleural effusions and malignant effusions. Am Rev Respir Dis 1968; 97:302.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/36\" class=\"nounderline abstract_t\">Taryle DA, Good JT Jr, Sahn SA. Acid generation by pleural fluid: possible role in the determination of pleural fluid pH. J Lab Clin Med 1979; 93:1041.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/37\" class=\"nounderline abstract_t\">Good JT Jr, Taryle DA, Sahn SA. The pathogenesis of low glucose, low pH malignant effusions. Am Rev Respir Dis 1985; 131:737.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/38\" class=\"nounderline abstract_t\">Sahn SA, Reller LB, Taryle DA, et al. The contribution of leukocytes and bacteria to the low pH of empyema fluid. Am Rev Respir Dis 1983; 128:811.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/39\" class=\"nounderline abstract_t\">Austin A, Jogani SN, Brasher PB, et al. The Urinothorax: A Comprehensive Review With Case Series. Am J Med Sci 2017; 354:44.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/40\" class=\"nounderline abstract_t\">Toubes ME, Lama A, Ferreiro L, et al. Urinothorax: a systematic review. J Thorac Dis 2017; 9:1209.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/41\" class=\"nounderline abstract_t\">Cheng DS, Rodriguez RM, Rogers J, et al. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 1998; 114:1368.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/42\" class=\"nounderline abstract_t\">Bowling M, Lenz P, Chatterjee A, et al. Perception versus reality: the measuring of pleural fluid pH in the United States. Respiration 2012; 83:316.</a></li><li class=\"breakAll\">Sahn SA. Pleural fluid pH in the normal state and in diseases affecting the pleural space. In: The Pleura in Health and Disease, Chretien J, Bignon J, Hirsch A (Eds), Marcel Dekker, New York 1985. p.253.</li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/44\" class=\"nounderline abstract_t\">Sahn SA, Willcox ML, Good JT Jr, et al. Characteristics of normal rabbit pleural fluid: physiologic and biochemical implications. Lung 1979; 156:63.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/45\" class=\"nounderline abstract_t\">Good JT Jr, Antony VB, Reller LB, et al. The pathogenesis of the low pleural fluid pH in esophageal rupture. Am Rev Respir Dis 1983; 127:702.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/46\" class=\"nounderline abstract_t\">Sahn SA, Good JT Jr. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann Intern Med 1988; 108:345.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/47\" class=\"nounderline abstract_t\">Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000; 117:73.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/48\" class=\"nounderline abstract_t\">Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000; 117:79.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/49\" class=\"nounderline abstract_t\">Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data. Chest 2000; 117:87.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/50\" class=\"nounderline abstract_t\">Heffner JE, Heffner JN, Brown LK. Multilevel and continuous pleural fluid pH likelihood ratios for draining parapneumonic effusions. Respiration 2005; 72:351.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/51\" class=\"nounderline abstract_t\">Jim&eacute;nez Castro D, D&iacute;az Nuevo G, Sueiro A, et al. Pleural fluid parameters identifying complicated parapneumonic effusions. Respiration 2005; 72:357.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/52\" class=\"nounderline abstract_t\">Porcel JM, Valencia H, Bielsa S. Factors influencing pleural drainage in parapneumonic effusions. Rev Clin Esp 2016; 216:361.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/53\" class=\"nounderline abstract_t\">Joseph J, Viney S, Beck P, et al. A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis. Chest 1992; 102:1455.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/54\" class=\"nounderline abstract_t\">Ok SJ, Kim IS, Lee EY, et al. A case of salivary-type amylase-producing multiple myeloma presenting as mediastinal plasmacytoma and myelomatous pleural effusion. Ann Lab Med 2014; 34:463.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/55\" class=\"nounderline abstract_t\">Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J 1978; 2:1751.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/56\" class=\"nounderline abstract_t\">Riantawan P, Chaowalit P, Wongsangiem M, Rojanaraweewong P. Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis. Chest 1999; 116:97.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/57\" class=\"nounderline abstract_t\">Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008; 102:744.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/58\" class=\"nounderline abstract_t\">Aggarwal AN, Agarwal R, Sehgal IS, et al. Meta-analysis of Indian studies evaluating adenosine deaminase for diagnosing tuberculous pleural effusion. Int J Tuberc Lung Dis 2016; 20:1386.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/59\" class=\"nounderline abstract_t\">Ogata Y, Aoe K, Hiraki A, et al. Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis? Acta Med Okayama 2011; 65:259.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/60\" class=\"nounderline abstract_t\">Biswas B, Sharma SK, Negi RS, et al. Pleural effusion: Role of pleural fluid cytology, adenosine deaminase level, and pleural biopsy in diagnosis. J Cytol 2016; 33:159.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/61\" class=\"nounderline abstract_t\">Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010; 21:419.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/62\" class=\"nounderline abstract_t\">Michot JM, Madec Y, Bulifon S, et al. Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings. Diagn Microbiol Infect Dis 2016; 84:215.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/63\" class=\"nounderline abstract_t\">Sivakumar P, Marples L, Breen R, Ahmed L. The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area. Int J Tuberc Lung Dis 2017; 21:697.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/64\" class=\"nounderline abstract_t\">Kumar S, Agarwal R, Bal A, et al. Utility of adenosine deaminase (ADA), PCR &amp; thoracoscopy in differentiating tuberculous &amp; non-tuberculous pleural effusion complicating chronic kidney disease. Indian J Med Res 2015; 141:308.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/65\" class=\"nounderline abstract_t\">Lee J, Lee SY, Lim JK, et al. Radiologic and laboratory differences in patients with tuberculous and parapneumonic pleural effusions showing non-lymphocytic predominance and high adenosine deaminase levels. Infection 2015; 43:65.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/66\" class=\"nounderline abstract_t\">Liu YC, Shin-Jung Lee S, Chen YS, et al. Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan. J Microbiol Immunol Infect 2011; 44:88.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/67\" class=\"nounderline abstract_t\">Kalantri Y, Hemvani N, Chitnis DS. Evaluation of real-time polymerase chain reaction, interferon-gamma, adenosine deaminase, and immunoglobulin A for the efficient diagnosis of pleural tuberculosis. Int J Infect Dis 2011; 15:e226.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/68\" class=\"nounderline abstract_t\">Klimiuk J, Safianowska A, Chazan R, et al. Development and Evaluation of the New Predictive Models in Tuberculous Pleuritis. Adv Exp Med Biol 2015; 873:53.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/69\" class=\"nounderline abstract_t\">Meldau R, Peter J, Theron G, et al. Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-&gamma; for the evaluation of pleural tuberculosis: a prospective cohort study. BMC Pulm Med 2014; 14:58.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/70\" class=\"nounderline abstract_t\">Liu F, Gao M, Zhang X, et al. Interferon-gamma release assay performance of pleural fluid and peripheral blood in pleural tuberculosis. PLoS One 2013; 8:e83857.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/71\" class=\"nounderline abstract_t\">Pang CS, Shen YC, Tian PW, et al. Accuracy of the interferon-gamma release assay for the diagnosis of tuberculous pleurisy: an updated meta-analysis. PeerJ 2015; 3:e951.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/72\" class=\"nounderline abstract_t\">Zhang L, Zhang Y, Shi X, et al. Utility of T-cell interferon-&gamma; release assays for diagnosing tuberculous serositis: a prospective study in Beijing, China. PLoS One 2014; 9:e85030.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/73\" class=\"nounderline abstract_t\">Aggarwal AN, Agarwal R, Gupta D, et al. Interferon Gamma Release Assays for Diagnosis of Pleural Tuberculosis: a Systematic Review and Meta-Analysis. J Clin Microbiol 2015; 53:2451.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/74\" class=\"nounderline abstract_t\">Kolditz M, Halank M, Schiemanck CS, et al. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 2006; 28:144.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/75\" class=\"nounderline abstract_t\">Tomcs&aacute;nyi J, Nagy E, Soml&oacute;i M, et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur J Heart Fail 2004; 6:753.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/76\" class=\"nounderline abstract_t\">Porcel JM, Vives M, Cao G, et al. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am J Med 2004; 116:417.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/77\" class=\"nounderline abstract_t\">Porcel JM, Mart&iacute;nez-Alonso M, Cao G, et al. Biomarkers of heart failure in pleural fluid. Chest 2009; 136:671.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/78\" class=\"nounderline abstract_t\">Zhou Q, Ye ZJ, Su Y, et al. Diagnostic value of N-terminal pro-brain natriuretic peptide for pleural effusion due to heart failure: a meta-analysis. Heart 2010; 96:1207.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/79\" class=\"nounderline abstract_t\">Porcel JM, Chorda J, Cao G, et al. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology 2007; 12:654.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/80\" class=\"nounderline abstract_t\">Long AC, O'Neal HR Jr, Peng S, et al. Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels. Chest 2010; 137:1369.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/81\" class=\"nounderline abstract_t\">Janda S, Swiston J. Diagnostic accuracy of pleural fluid NT-pro-BNP for pleural effusions of cardiac origin: a systematic review and meta-analysis. BMC Pulm Med 2010; 10:58.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/82\" class=\"nounderline abstract_t\">Han ZJ, Wu XD, Cheng JJ, et al. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis. PLoS One 2015; 10:e0134376.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/83\" class=\"nounderline abstract_t\">Yeh JH, Huang CT, Liu CH, et al. Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients. PLoS One 2014; 9:e115301.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/84\" class=\"nounderline abstract_t\">Davies J. Procalcitonin. J Clin Pathol 2015; 68:675.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/85\" class=\"nounderline abstract_t\">Lee SH, Lee EJ, Min KH, et al. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Clin Biochem 2013; 46:1484.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/86\" class=\"nounderline abstract_t\">Zou MX, Zhou RR, Wu WJ, et al. The use of pleural fluid procalcitonin and C-reactive protein in the diagnosis of parapneumonic pleural effusions: a systemic review and meta-analysis. Am J Emerg Med 2012; 30:1907.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/87\" class=\"nounderline abstract_t\">He C, Wang B, Li D, et al. Performance of procalcitonin in diagnosing parapneumonic pleural effusions: A clinical study and meta-analysis. Medicine (Baltimore) 2017; 96:e7829.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/88\" class=\"nounderline abstract_t\">Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol 2014; 50:161.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/89\" class=\"nounderline abstract_t\">Hooper C, Lee YC, Maskell N, BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii4.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/90\" class=\"nounderline abstract_t\">Wu H, Khosla R, Rohatgi PK, et al. The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study. Lung India 2017; 34:34.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/91\" class=\"nounderline abstract_t\">Light RW. Tumor markers in undiagnosed pleural effusions. Chest 2004; 126:1721.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/92\" class=\"nounderline abstract_t\">Liang QL, Shi HZ, Qin XJ, et al. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 2008; 63:35.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/93\" class=\"nounderline abstract_t\">Porcel JM, Vives M, Esquerda A, et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004; 126:1757.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/94\" class=\"nounderline abstract_t\">Nguyen AH, Miller EJ, Wichman CS, et al. Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis. Transl Res 2015; 166:432.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/95\" class=\"nounderline abstract_t\">Sturges S, Brown M. Polypsychopharmacy. Bull Menninger Clin 1975; 39:274.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/96\" class=\"nounderline abstract_t\">Hassan R, Remaley AT, Sampson ML, et al. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 2006; 12:447.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/97\" class=\"nounderline abstract_t\">Panou V, Vyberg M, Weinreich UM, et al. The established and future biomarkers of malignant pleural mesothelioma. Cancer Treat Rev 2015; 41:486.</a></li><li class=\"breakAll\">Light RW. Pleural diseases, 3rd ed, Williams &amp; Wilkins, Baltimore 1995.</li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/99\" class=\"nounderline abstract_t\">Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967; 66:972.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/100\" class=\"nounderline abstract_t\">Ferreiro L, San-Jos&eacute; E, Su&aacute;rez-Antelo J, Vald&eacute;s L. Dasatinib-induced pleural effusion: Chylothorax, an option to consider. Ann Thorac Med 2016; 11:289.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/101\" class=\"nounderline abstract_t\">Chu FY, Liou CB, Sun JT, et al. Eosinophilia in Pleural Effusions: a Speculative Negative Predictor for Malignancy. Asian Pac J Cancer Prev 2016; 17:1411.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/102\" class=\"nounderline abstract_t\">Fatimi SH, Deedar-Ali-Khawaja R. Catamenial pneumothorax associated with ascites, eosinophilic pleural effusion, and relatively low glucose content. Am Surg 2010; 76:E212.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/103\" class=\"nounderline abstract_t\">Mehta AA, Venkatakrishnan R, Jose W, et al. Multiple myeloma presenting as eosinophilic pleural effusion. Asia Pac J Clin Oncol 2010; 6:256.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/104\" class=\"nounderline abstract_t\">Sriratanaviriyakul N, La HH, Albertson TE. Chronic eosinophilic pneumonia presenting with ipsilateral pleural effusion: a case report. J Med Case Rep 2016; 10:227.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/105\" class=\"nounderline abstract_t\">Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest 1996; 110:1271.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/106\" class=\"nounderline abstract_t\">Mart&iacute;nez-Garc&iacute;a MA, Cases-Viedma E, Cordero-Rodr&iacute;guez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 2000; 15:166.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/107\" class=\"nounderline abstract_t\">Light RW, Erozan YS, Ball WC Jr. Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med 1973; 132:854.</a></li><li><a href=\"https://www.uptodate.com/contents/diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing/abstract/108\" class=\"nounderline abstract_t\">Hurwitz S, Leiman G, Shapiro C. Mesothelial cells in pleural fluid: TB or not TB? S Afr Med J 1980; 57:937.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6698 Version 24.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H365048\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">INDICATIONS FOR THORACENTESIS</a></li><li><a href=\"#H4636315\" id=\"outline-link-H4636315\">CONDITIONS DIAGNOSED BY THORACENTESIS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PLEURAL FLUID ANALYSIS</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Gross appearance</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Characterization</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">- Transudates</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Exudates</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Diagnostic criteria</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">Chemical and biochemical analysis</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">- Protein</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- LDH</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Cholesterol</a></li><li><a href=\"#H25763845\" id=\"outline-link-H25763845\">- Triglycerides</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">- Glucose</a></li><li><a href=\"#H2582864087\" id=\"outline-link-H2582864087\">- Creatinine</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">- pH</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Amylase</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">- Adenosine deaminase</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">- N-terminal pro-BNP</a></li><li><a href=\"#H2578926\" id=\"outline-link-H2578926\">- Procalcitonin</a></li></ul></li><li><a href=\"#H3293930968\" id=\"outline-link-H3293930968\">Cytology</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">Cancer-related biomarkers</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Nucleated cells</a><ul><li><a href=\"#H20\" id=\"outline-link-H20\">- Lymphocytosis</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">- Eosinophilia</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">- Mesothelial cells</a></li></ul></li></ul></li><li><a href=\"#H23\" id=\"outline-link-H23\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H1018584325\" id=\"outline-link-H1018584325\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H7170464\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H365048\" id=\"outline-link-H365048\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PULM/6698|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/50027\" class=\"graphic graphic_table\">- Dx by pleural fluid analysis</a></li><li><a href=\"image.htm?imageKey=PULM/74757\" class=\"graphic graphic_table\">- Pleural fluid characteristics</a></li><li><a href=\"image.htm?imageKey=PULM/73530\" class=\"graphic graphic_table\">- Transudative pleural effusions</a></li><li><a href=\"image.htm?imageKey=PULM/54055\" class=\"graphic graphic_table\">- Exudative pleural effusions</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=aids-related-lymphomas-primary-effusion-lymphoma\" class=\"medical medical_review\">AIDS-related lymphomas: Primary effusion lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-diagnosis-and-management-of-cholesterol-effusions\" class=\"medical medical_review\">Clinical presentation, diagnosis and management of cholesterol effusions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology\" class=\"medical medical_review\">Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-clinical-presentation-and-diagnosis-of-chylothorax\" class=\"medical medical_review\">Etiology, clinical presentation, and diagnosis of chylothorax</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=imaging-of-pleural-effusions-in-adults\" class=\"medical medical_review\">Imaging of pleural effusions in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-malignant-pleural-effusions\" class=\"medical medical_review\">Management of malignant pleural effusions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mechanisms-of-pleural-liquid-accumulation-in-disease\" class=\"medical medical_review\">Mechanisms of pleural liquid accumulation in disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=natriuretic-peptide-measurement-in-heart-failure\" class=\"medical medical_review\">Natriuretic peptide measurement in heart failure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults\" class=\"medical medical_review\">Parapneumonic effusion and empyema in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pleural-effusion-the-basics\" class=\"medical medical_basics\">Patient education: Pleural effusion (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=thoracentesis-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Thoracentesis (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pleural-effusions-in-hiv-infected-patients\" class=\"medical medical_review\">Pleural effusions in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pleural-fluid-eosinophilia\" class=\"medical medical_review\">Pleural fluid eosinophilia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=presentation-initial-evaluation-and-prognosis-of-malignant-pleural-mesothelioma\" class=\"medical medical_review\">Presentation, initial evaluation, and prognosis of malignant pleural mesothelioma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=procedures-for-tissue-biopsy-in-patients-with-suspected-non-small-cell-lung-cancer\" class=\"medical medical_review\">Procedures for tissue biopsy in patients with suspected non-small cell lung cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pulmonary-manifestations-of-systemic-lupus-erythematosus-in-adults\" class=\"medical medical_review\">Pulmonary manifestations of systemic lupus erythematosus in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=selection-of-modality-for-diagnosis-and-staging-of-patients-with-suspected-non-small-cell-lung-cancer\" class=\"medical medical_review\">Selection of modality for diagnosis and staging of patients with suspected non-small cell lung cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-pleural-effusion\" class=\"medical medical_society_guidelines\">Society guideline links: Pleural effusion</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tuberculous-pleural-effusion\" class=\"medical medical_review\">Tuberculous pleural effusion</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ultrasound-guided-thoracentesis\" class=\"medical medical_review\">Ultrasound-guided thoracentesis</a></li></ul></div></div>","javascript":null}